Gennaro Calendo

7PUBLICATIONS
64CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 28, 2026
TEDEdb: A multicohort analysis and resource for transposable element differential expression in cancer.

|Oct 08, 2026
Targeting YAP/TEAD signaling disturbs RNA Pol II activity and enhances immunotherapy response via activated cytosolic DNA sensing pathway in gastroesophageal cancer.

|Aug 01, 2026
Ribonucleotide Reductase Inhibition Overcomes FLT3 Inhibitor Resistance in Acute Myeloid Leukemia.

|Jan 13, 2025
ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer.

Lora Stojanovic, Rachel Abbotts, Kaushelendra Tripathi

|Jun 11, 2024
Association between gut microbiota and CpG island methylator phenotype in colorectal cancer.

Pyoung Hwa Park, Kelsey Keith, Gennaro Calendo

|Oct 23, 2023
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD.

Ying Wang, Shan He, Gennaro Calendo

Pageof 2

Frequent Collaborators

4 joint publications

Jozef Madzo

4 joint publications

Jean-Pierre J Issa

2 joint publications

Pyounghwa Park

2 joint publications

Kelsey Keith